Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Most hospitalized internal medicine patients have undiagnosed skin problems and want them treated.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

Certain natural compounds called terpenes may help prevent prostate cancer.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

PCOS increases the risk of heart disease and type 2 diabetes in women.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.